| 期刊論文1. | Cotier, S. J.、Wartelle, C. F.、Larson, A. M.、Gretch, D. R.、Jensen, D. M.、Carithers, R. L. Jr.(2000)。Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C。Journal of Viral Hepatologyy,7(3),211-217。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 2. | Bayliss, M. S.、Gandek, B.、Bungay, K. M.、Sugano, D.、Hsu, M. A.、Ware, J. E. Jr.(1998)。A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C。Quality of Life Reasearchy,7(1),39-55。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 3. | Foster, G. R.(1999)。Hepatitis C virus infection: Quality of life and side effects of treatment。Journal of Hepatology,31(1),250-254。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 4. | Fried, M. W.、Shiffman, M. L.、Reddy, K. R.、Smith, C.、Marinos, G.、Goncales, F. L. Jr.(2002)。Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection。The New England Journal of Medicine,347(13),975-982。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 5. | Gifford, S. M.、O’Brien, M. L.、Bammer, G.、Banwell, C.、Stoove, M.(2003)。Australian women’s experiences of living with hepatitis C virus: Results from a cross-sectional survey。Journal of Gastroenterology and Hepatologyy,18(1),841-850。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 6. | Gifford, S. M.、O’Brien, M. L.、Smith, A.、Templesmith, M.、Stoove, M.、Mitchell, D.(2005)。Australian men’s experiences of living with hepatitis C virus: Results from a cross-secdonal survey。Journal of Gastroenterology and Hepatology,20(1),79-86。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 7. | Glacken, M.、Coates, V.、Kemohan, G.、Hegarty, J.(2003)。The experience of fatigue for people living with hepatitis C virus。Journal of Clinical Nursing,72(2),244-253。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 8. | Hassanein, T.、Cooksley, G.、Sulkowski, M.、Smith, C.、Marinos, G.、Lai, M. Y.(2004)。The impact of peginterferon alfa-2a plus ribavirin combination therapy on healthrelated quality of life in chronic hepatitis C。Journal of Hepatology,40(4),675-681。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 9. | Heitkemper, M.、Jarrett, M.、Kurashige, E. M.、Carithers, R.(2000)。Chronic hepatitis C implications for health-related quality of life。Gastroenterology Nursing,24(4),170-177。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 10. | Hopwood, M.、Southgat, E.(2003)。Living with hepatitis C: A sociological review。Critical Public Health,75(3),251-261。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 11. | Hopwood, M.、Treloar, C.(2005)。The experience of interferon-based treatments for hepatitis C infection。Qualitative Health Research,75(5),635-646。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 12. | Kahn, D. L.(1993)。Ways of discussing validity in qualitative nursing research。Western Journal of Nursing Research,75(1),122-125。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 13. | Kleinman, L.、Zodet, M. W.、Hakim, Z.、Aledort, J.、Barker, C.、Chan, K.(2000)。Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C。Quality of Life Research,9(5),499-508。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 14. | McHutchison, J. G.、Ware, J. E. Jr.、Baylisst M. S.、Pianko, S.、Albrecht, J. K.、Cort, S.(2001)。The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity。Journal of Hepatology,34(1),140-147。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 15. | Perrillo, R.、Rothstein, K. D.、Rubin, R.、Alam, I.、Imperiai, J.、Harb, G.(2004)。Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C。Journal of Viral Hepatitis,77(2),157-165。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 16. | Rasenack, J.、Zeuzem, S.、Feinman, S. V.、Heathcote, E. J.、Manns, M. I.、Yoshida, E. M.(2003)。Peginterferon alfa-2a in patients with chronic hepatitis C。Pharmaco Economics,27(5),341-349。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 17. | Ware, J. E. Jr.、Bayliss, S.、Mannocchia, M.、Davis, G. L.(1999)。Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response。Hepatology,29(6),3-6。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 18. | Wright, I. A.(2000)。Monitoring depression in patients undergoing alpha-interferon and ribavirin for hepatitis C。Gastroenterology Nursing,23(6),275-280。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 19. | 許景盛、高嘉宏(20050300)。C型肝炎治療的新進展--干擾素相關治療的影響因素和因應策略。當代醫學,32(3)=377,218-231。 延伸查詢![new window](/gs32/images/newin.png) | 20. | 梁程超、高嘉宏(20030400)。2002年C型肝炎治療共識簡介。當代醫學,30(4)=354,314-319。 延伸查詢![new window](/gs32/images/newin.png) | 21. | 劉俊人、賴明陽(19981100)。慢性C型肝炎之治療。臺灣醫學,2(6),661-667。 延伸查詢![new window](/gs32/images/newin.png) | 22. | 賴明陽(20030200)。C型肝炎治療的最新進展。臨床醫學,51(2)=302,96-100。 延伸查詢![new window](/gs32/images/newin.png) | 學位論文1. | 趙美珍(2004)。肝硬化病患疲倦與睡眠品質之相關因素探討(碩士論文)。臺北醫學大學。 延伸查詢![new window](/gs32/images/newin.png) | 2. | 傅淑瑩(2000)。慢性病毒性肝炎患者接受干擾素治療期間之疲倦感與自我照顧行為的探討(碩士論文)。高雄醫學大學。 延伸查詢![new window](/gs32/images/newin.png) | 3. | 鐘孟錐(2003)。六週次大運動訓練對B型肝炎學生肝功能及疲勞度之影響(碩士論文)。國立臺灣師範大學。 延伸查詢![new window](/gs32/images/newin.png) | 圖書1. | Giorgi, A.(1988)。Phenomenology and psychological research。Pittsburgh, PA:Duquesnw University Press。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 2. | Lincoln, Yvonna S.、Guba, Egon G.(1985)。Naturalistic Inquiry。Sage。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | |